Related Experiment Video
Updated: Jan 13, 2026
07:52
Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
Published on: July 23, 2012
15.4K
CD207-Positive Dendritic Cells Promote Emphysema Through CD8+ T Cell Pathway in Chronic Obstructive Pulmonary Disease
Shurui Xuan1,2, Yunhui Wu1, Feng Liu3
1Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|January 7, 2026
Summary
CD207-positive dendritic cells (CD207+ DCs) drive emphysema progression in chronic obstructive pulmonary disease (COPD). Targeting these cells could offer a new therapeutic strategy for emphysema management.
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- Emphysema, a component of chronic obstructive pulmonary disease (COPD), presents significant management challenges.
- CD207-positive dendritic cells (CD207+ DCs) are increasingly recognized for their role in immune responses.
Purpose of the Study:
- To investigate the role of CD207+ DCs in the pathogenesis of emphysema.
- To identify CD207+ DCs as potential therapeutic targets for emphysema.
Main Methods:
- Correlation analysis of CD207+ DC abundance with emphysema severity and lung function in COPD patients.
- Adoptive transfer experiments of CD207+ DCs in a murine emphysema model.
- Investigation of the mechanisms underlying CD207+ DC expansion and activation.
Main Results:
- Increased abundance of CD207+ DCs in small airways of COPD patients correlates with emphysema severity and reduced lung function (FEV1%pred).
- Adoptive transfer of CD207+ DCs exacerbated emphysema, inflammation, and CD8+ T-cell responses in CD207-knockout mice.
- Cigarette smoke-induced GM-CSF drives CD207+ DC expansion, which then promote CD8+ T-cell responses via MHC-I cross-presentation.
Conclusions:
- CD207+ DCs are key mediators of emphysema progression by orchestrating pathogenic CD8+ T-cell responses.
- CD207+ DCs represent a promising therapeutic target for treating emphysema in COPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K